These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38353682)

  • 1. Relevance of mexiletine in the era of evolving antiarrhythmic therapy of ventricular arrhythmias.
    Alhourani N; Wolfes J; Könemann H; Ellermann C; Frommeyer G; Güner F; Lange PS; Reinke F; Köbe J; Eckardt L
    Clin Res Cardiol; 2024 Jun; 113(6):791-800. PubMed ID: 38353682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for mexiletine in the new ESC guidelines and beyond.
    Vamos M; Zsigmond EJ; Hohnloser SH
    Expert Opin Pharmacother; 2023; 24(12):1403-1407. PubMed ID: 37306465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mexiletine: Antiarrhythmic mechanisms, emerging clinical applications and mortality.
    Olleik F; Kamareddine MH; Spears J; Tse G; Liu T; Yan GX
    Pacing Clin Electrophysiol; 2023 Nov; 46(11):1348-1356. PubMed ID: 37846818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.
    Monk JP; Brogden RN
    Drugs; 1990 Sep; 40(3):374-411. PubMed ID: 2226221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dramatic reduction of ventricular tachycardia burden after dronedarone plus mexiletine treatment in a patient refractory to hybrid ablation.
    Frutos-López M; Pedrote A; Acosta-Martínez J; Arana-Rueda E
    Rev Port Cardiol (Engl Ed); 2020 Mar; 39(3):171-173. PubMed ID: 32336522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of mexiletine in therapy-refractory recurrent ventricular tachycardia storm.
    Szonyi MD; Pap R; Vamos M
    Herzschrittmacherther Elektrophysiol; 2023 Dec; 34(4):326-329. PubMed ID: 37917362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of pure potassium channel blocker nifekalant and sodium channel blocker mexiletine on malignant ventricular tachyarrhythmias.
    Otuki S; Hasegawa K; Watanabe H; Katsuumi G; Yagihara N; Iijima K; Sato A; Izumi D; Furushima H; Chinushi M; Aizawa Y; Minamino T
    J Electrocardiol; 2017; 50(3):277-281. PubMed ID: 28238302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology of the long QT syndrome: impact on management.
    Priori SG; Napolitano C; Paganini V; Cantù F; Schwartz PJ
    Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2052-7. PubMed ID: 9272507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mexiletine for ventricular arrhythmias in patients with chronic coronary syndrome: a cohort study.
    Mugnai G; Paolini C; Cavedon S; Mecenero A; Perrone C; Bilato C
    Acta Cardiol; 2022 May; 77(3):264-270. PubMed ID: 34006205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad antiarrhythmic effect of mexiletine in different arrhythmia models.
    Frommeyer G; Garthmann J; Ellermann C; Dechering DG; Kochhäuser S; Reinke F; Köbe J; Wasmer K; Eckardt L
    Europace; 2018 Aug; 20(8):1375-1381. PubMed ID: 29016765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mexiletine: an effective antiarrhythmic drug for treatment of ventricular arrhythmias in congenital heart disease.
    Moak JP; Smith RT; Garson A
    J Am Coll Cardiol; 1987 Oct; 10(4):824-9. PubMed ID: 3655149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mexiletine: pharmacology and therapeutic use.
    Manolis AS; Deering TF; Cameron J; Estes NA
    Clin Cardiol; 1990 May; 13(5):349-59. PubMed ID: 2189614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination of sotalol with the class I B substances mexiletine or tocainide in complex ventricular extrasystole].
    Wagner WL; Manz M; Lüderitz B
    Z Kardiol; 1987 May; 76(5):296-302. PubMed ID: 2441535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral mexiletine in the treatment of refractory ventricular arrhythmias: the role of electrophysiologic techniques.
    Schoenfeld MH; Whitford E; McGovern B; Garan H; Ruskin JN
    Am Heart J; 1984 May; 107(5 Pt 2):1071-8. PubMed ID: 6372423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
    Whitford EG; McGovern B; Schoenfeld MH; Garan H; Newell JB; McElroy M; Ruskin JN
    Am Heart J; 1988 Feb; 115(2):360-6. PubMed ID: 3341170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular tachyarrhythmias in a canine model of LQT3: arrhythmogenic effects of sympathetic activity and therapeutic effects of mexiletine.
    Chinushi M; Tagawa M; Sugiura H; Komura S; Hosaka Y; Washizuka T; Aizawa Y
    Circ J; 2003 Mar; 67(3):263-8. PubMed ID: 12604879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mexiletine Suppressed Recurrent Ventricular Tachycardia Triggered by Hemodialysis in an Old Patient with LQT2.
    Kang Y; Wei J
    Int Heart J; 2019 Sep; 60(5):1189-1191. PubMed ID: 31447465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.